Cathie Wood Just Bought $17 Million of Cerebras Stock. Wall Street Sees 59% Upside.
Market Updates

Cathie Wood Just Bought $17 Million of Cerebras Stock. Wall Street Sees 59% Upside.

Yahoo! Finance9d ago

Cathie Wood is doubling down on Cerebras Systems (CBRS) at a time when the artificial intelligence (AI) chip stock is struggling to regain its footing. Ark Invest bought another 93,290 Cerebras shares on Aug. 25 across multiple exchange-traded funds (ETFs), worth roughly $17.2 million based on the reported purchase value. That follows additional buying earlier in August.

The timing is notable. Shares of Cerebras have fallen sharply from their May peak and remain extremely volatile. CBRS stock is down 7% over the past month and 26% over the past three months. The stock has swung between a 52-week high of $386.34 and a low of $160.81.

More News from Barchart

Why is Wood buying the dip? Let's take a closer look.

Cerebras Stock Is Still a High-Growth AI Bet

The answer starts with Cerebras' positioning in the fast-growing AI inference market. Unlike Nvidia (NVDA), which dominates the broader GPU market, Cerebras focuses on wafer-scale computing designed to deliver extremely fast AI inference. That could become increasingly important as businesses move from training AI models toward running them in real time.

Cerebras has also been expanding beyond selling AI accelerators. It is building an inference cloud business and working with major technology companies including OpenAI, Amazon's (AMZN) Amazon Web Services (AWS), and Advanced Micro Devices (AMD).

The company recently unveiled its CS-4 system, which it says can deliver up to 30 times faster inference than GPU-based alternatives. Cerebras is also working with AMD on a disaggregated inference architecture that can deliver up to five times higher throughput per watt in certain configurations.

That gives Wood a larger thesis than simply betting on another chip company. She is effectively betting that AI inference becomes one of the biggest infrastructure markets of the next decade.

Cerebras' Valuation Leaves Little Room for Error

The biggest risk is valuation. Cerebras currently has a market capitalization of about $42.5 billion and annual sales of roughly $510 million. The price-to-sales (P/S) ratio is 60 times, an enormous premium for a company that is still losing money on a GAAP basis.

Originally published by Yahoo! Finance

Read original source →
Cerebras